These and other studies have demonstrated that the mitogen-activated protein kinase (MAPK) pathway, which includes KRAS, NRAS and BRAF genes, is the most commonly mutated signalling pathway in MM. This evidence concerns the gene KRAS and Miyoshi myopathy.